Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Brain Neoplasms × toripalimab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Mouth Neoplasms 1 Melanoma 1 Local Advanced Non-small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Tumors 1 Adenocarcinoma Of Esophagus 1

Interventions

Radiosurgery 11 Magnetic Resonance Spectroscopy 8 Temozolomide 7 Bevacizumab 6 Specimen Handling 5 trastuzumab deruxtecan 4 pembrolizumab 4 Radiotherapy 4 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 abemaciclib 3 Ipilimumab 3 entrectinib 2 cabozantinib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sirolimus 2 Receptors, Interleukin-8B 2 Mental Status and Dementia Tests 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dexamethasone 2 Adrenal Cortex Hormones 2 trastuzumab biosimilar HLX02 1 temsirolimus 1 ribociclib 1 repotrectinib 1 regorafenib 1 pertuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡